RAPIDPoint 500 Measurement Cartridge Sodium Sensor May Cause Measurement Error
Siemens RAPIDPoint 500 cartridges may produce inaccurate sodium measurements in blood samples, potentially delaying diagnosis or causing inappropriate treatment. The sodium sensor may show a negative bias, affecting patient care.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a diagnostic device with a sensor defect that could produce measurement errors, potentially leading to delayed diagnosis or inappropriate treatment. No illnesses or injuries have been reported; under the rubric, risk-of-harm products where injury has not yet been reported score at most 3 (High).
Plain-English summary
Siemens Healthcare Diagnostics has recalled RAPIDPoint 500 Systems Measurement Cartridges (with Lactate) 400 due to a potential defect in the sodium (Na+) sensor. These are in-vitro diagnostic devices designed to measure sodium levels in whole blood samples.
The sodium sensor may produce a negative bias in measurements. This could result in delayed diagnosis of high sodium levels (hypernatremia) or unnecessary treatment for low sodium levels (hyponatremia). In cases where the true sodium result is near critical thresholds, the measurement error could lead to serious clinical consequences, including treatment-induced high sodium levels (iatrogenic hypernatremia). Additionally, the defect may cause error flags for multiple electrolyte readings that could delay diagnosis or treatment.
The recalled cartridges were distributed nationwide and to multiple countries worldwide. Approximately 6,611 cartridges were distributed in the United States. The recall affects laboratory facilities and hospitals using these cartridges for patient blood sodium testing.
The recalled product
- Product
- RAPIDPoint 500 Systems Measurement Cartridge (with Lactate) 400-Intended for in vitro diagnostic use and is designed to provide the determination in whole blood. SMN: 10491448
- Manufacturer
- Siemens Healthcare Diagnostics Inc
- Affected units
- 6,611
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI-DI: 00630414589763 All serial numbers
Distribution
Part of a larger recall action
This product is one of 4 recalled by Siemens Healthcare Diagnostics Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics Inc
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · measurement bias
See all →- HighEmano Flow Uroflowmetry App Recalled Over Biased Flow Estimates
FDA (Devices) · 2026-07-29
- HighStago D-dimer assay shows positive bias across entire analytical range
FDA (Devices) · 2026-03-25
- HighCapillary tubes recalled over a positive bias in potassium results
FDA (Devices) · 2026-02-25
- HighVITROS Chemistry CRP Diagnostic Slides May Underreport Elevated Results
FDA (Devices) · 2024-12-04
- Highepoc BGEM BUN Test Cards recalled for sodium measurement bias
FDA (Devices) · 2024-11-13